Aspira Women’s Health receives $1.5M milestone payment from ARPA-H

Aspira Women’s Health (AWH) announced the successful completion of the second development milestone of its Advanced Research Projects Agency for Health award. As a result of satisfying the second development milestone, Aspira received a $1.5M cash payment under the terms of the related $10M agreement. Aspira is expected to receive a total of $10M in funding over two years through the Sprint for Women’s Health launchpad track for later-stage health solutions. The company’s multi-marker blood test to aid in the detection of endometriosis, which it intends to launch commercially prior to the end of the contract term, will rely on a powerful AI-enabled algorithm that combines protein and microRNA biomarkers and patient data, and leverages technology that Aspira pioneered for its commercially successful ovarian cancer risk assessment blood tests.